← FDA Drug Approvals (Drugs@FDA)

NANDROLONE DECANOATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ABRAXIS PHARM · Approved 1989-03-17

Drug application

FDA Application #

ANDA088290

Application type

Abbreviated New Drug Application (Generic)

Brand name

NANDROLONE DECANOATE

Generic name

Nandrolone Decanoate

Active ingredients

NANDROLONE DECANOATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

ABRAXIS PHARM

First approval

1989-03-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown